dc.contributor.author |
Khabibulina V. |
|
dc.contributor.author |
Yurchenko N. |
|
dc.contributor.author |
Korostelev S. |
|
dc.contributor.author |
Shashkina M. |
|
dc.contributor.author |
Sergeev A. |
|
dc.date.accessioned |
2018-09-17T21:52:55Z |
|
dc.date.available |
2018-09-17T21:52:55Z |
|
dc.date.issued |
1997 |
|
dc.identifier.issn |
0042-8809 |
|
dc.identifier.uri |
https://dspace.kpfu.ru/xmlui/handle/net/135558 |
|
dc.description.abstract |
Possibility of including of synthetic beta-carotene in variuos courses of chemotherapy of lympholeucosis of mice BDF1 was investigated. In experimental models cyclophosphan and platidiam (50, 100, 200 and 8 mg/kg b.w. respectively) was used as anticancer drugs. Beta-carotene (5, 10, 20, 50 mg/kg b.w.) was administrated to mice in different schemes. During experiments it was observed that beta-carotene does not effect the rapeutic action of cyclophósphan and platidiam during treatment of lympholeucosis L1210. |
|
dc.relation.ispartofseries |
Voprosy Meditsinskoj Khimii |
|
dc.subject |
Beta-carotene |
|
dc.subject |
Chemotherapy |
|
dc.subject |
Experimental models |
|
dc.subject |
Lympholeucosis |
|
dc.title |
Inclusion of beta-carotene in various courses of chemotherapy of lympholeucosis L1210 |
|
dc.type |
Article |
|
dc.relation.ispartofseries-issue |
2 |
|
dc.relation.ispartofseries-volume |
43 |
|
dc.collection |
Публикации сотрудников КФУ |
|
dc.relation.startpage |
97 |
|
dc.source.id |
SCOPUS00428809-1997-43-2-SID5344258234 |
|